Global Bioprocess Automation Software Market Growth (Status and Outlook) 2023-2029
LPI (LP Information)' newest research report, the “Bioprocess Automation Software Industry Forecast” looks at past sales and reviews total world Bioprocess Automation Software sales in 2022, providing a comprehensive analysis by region and market sector of projected Bioprocess Automation Software sales for 2023 through 2029. With Bioprocess Automation Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioprocess Automation Software industry.
This Insight Report provides a comprehensive analysis of the global Bioprocess Automation Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioprocess Automation Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioprocess Automation Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioprocess Automation Software and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioprocess Automation Software.
The global Bioprocess Automation Software market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bioprocess Automation Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bioprocess Automation Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bioprocess Automation Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bioprocess Automation Software players cover Thermo Fisher Scientific, Rockwell Automation, Agilitech, Amgen, Andrew Alliance (acquired by Waters), Synthace, Merck Millipore, Automated Control Concepts (ACC) and Bioengineering, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioprocess Automation Software market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Upstream Bioprocessing
Downstream Bioprocessing
Segmentation by application
Laboratory
Clinical
Commercial
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Rockwell Automation
Agilitech
Amgen
Andrew Alliance (acquired by Waters)
Synthace
Merck Millipore
Automated Control Concepts (ACC)
Bioengineering
BIONET
Lonza
BlueSens gas sensor
Repligen
CSL Behring
Roche
Danaher Corporation
DISTek
Parker Hannifin
Eppendorf
Flotek
Flownamics
Pierre Guerin
Getinge
Sartorius Stedim Biotech
Securecell
ILS Automation
INFORS HT
Inscripta
PendoTECH
Genedata
Please note: The report will take approximately 2 business days to prepare and deliver.